Log In
Print
BCIQ
Print
Print this Print this
 

VRS-826

  Manage Alerts
Collapse Summary General Information
Company Amunix Inc.
DescriptionInterleukin-1 (IL-1) receptor antagonist attached to Amunix's recombinant XTEN technology
Molecular Target Interleukin-1 (IL-1) receptor
Mechanism of ActionInterleukin-1 (IL-1) receptor antagonist
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today